Cartesian Therapeutics - 53 Year Dividend History | RNAC

Historical dividend payout and yield for Cartesian Therapeutics (RNAC) since 1971. The current TTM dividend payout for Cartesian Therapeutics (RNAC) as of May 22, 2024 is $0.00. The current dividend yield for Cartesian Therapeutics as of May 22, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.136B $0.026B
Cartesian Therapeutics is a clinical-stage company pioneering RNA cell therapies for the treatment of autoimmune diseases. The company's lead asset, Descartes-08, is a potential first-in-class, RNA-engineered chimeric antigen receptor T-cell therapy in Phase 2b clinical development for patients with generalized myasthenia gravis. Cartesian Therapeutics, formerly known as Selecta Biosciences Inc., is based in WATERTOWN, Mass.
Stock Name Country Market Cap PE Ratio